Document is current
Any future updates will be listed below
-
Authors
Fons, Nathan R.
Sundaram, Ranjini K.
Breuer, Gregory A.
Peng, Sen
McLean, Ryan L.
Kalathil, Aravind N.
Schmidt, Mark S. http://orcid.org/0000-0003-4593-4096
Carvalho, Diana M.
Mackay, Alan
Jones, Chris
Carcaboso, Ángel M. http://orcid.org/0000-0002-8485-426X
Nazarian, Javad
Berens, Michael E. http://orcid.org/0000-0002-3382-6787
Brenner, Charles http://orcid.org/0000-0002-4955-3226
Bindra, Ranjit S. http://orcid.org/0000-0002-3255-0467
- License Information
-
More Information
Article History
Received: 6 November 2018
Accepted: 1 August 2019
First Online: 22 August 2019
Competing interests
: C.B. is the inventor of intellectual property on nicotinamide riboside, which was developed by ChromaDex Inc. C.B. owns equity in ChromaDex and serves as their chief scientific advisor. C.B. is on the scientific advisory board of ChromaDex and Cytokinetics. All remaining authors declare no competing interests.
